Belun Ring Platform With an Improved Algorithm for OSA Assessment
NCT: NCT04885062 · COMPLETED
Brief Summary
OSA is commonly diagnosed with either attended in-lab polysomnography (PSG) or unattended home sleep apnea testing (HSAT). The BLS-100 (Belun Technology Company Limited, Hong Kong) is a novel neural network-based HSAT platform consists of a ring shape pulse oximeter sensor, a cradle, and an improved proprietary analytic algorithm. This study investigates the hypothesis that the BLS-100 is a reasonable HSAT device for OSA assessment.
Frequently Asked Questions
What is Belun Ring Platform With an Improved Algorithm for OSA Assessment?
Belun Ring Platform With an Improved Algorithm for OSA Assessment is a clinical trial registered under NCT04885062. Current status: COMPLETED.
What is the status of NCT04885062?
The current status of NCT04885062 (Belun Ring Platform With an Improved Algorithm for OSA Assessment) is: COMPLETED.
When did Belun Ring Platform With an Improved Algorithm for OSA Assessment start?
Belun Ring Platform With an Improved Algorithm for OSA Assessment started on 2021-02-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.